Top Biopharmaceutical Companies in United Arab Emirates

Biotech Pharma is a pharmaceutical company that focuses on acquiring and in-licensing products in areas like Hematology and Oncology, which aligns with the biopharmaceutical sector. With over a decade of experience, they emphasize quality and reliable delivery of medications, making them a key player in the pharmaceutical market.

Biologix plays a crucial role in the biopharmaceutical landscape by assisting multinational pharmaceutical manufacturers in introducing innovative drugs to the Middle East and North Africa (MENA) region, with a strong focus on rare disease management and therapeutic lines.

Hayat Biotech, established as a joint venture between Sinopharm CNBG and G42, focuses on delivering innovative biotechnological solutions, including biologics, biosimilars, human vaccines, and monoclonal antibodies. Their commitment to advancing vaccine technology and distributing preventive medications highlights their role in the biopharmaceutical landscape.

EarlyHealth Group (EHG) is a global pharmaceutical company focused on improving patient access to medication in the life sciences industry. Their commitment to enhancing the downstream processes ensures that patients receive earlier access to essential treatments.

The company, a leading pharmaceutical market access firm, specializes in niche therapeutics for rare diseases and specialty care. They facilitate rapid and sustainable market access in the MENAT region, connecting innovative global biotech companies with local healthcare providers to ensure that patients receive cutting-edge treatments for rare diseases.

NewBridge Pharmaceuticals is a specialty company focused on partnering with global pharma and biotech firms to in-license and commercialize innovative therapeutics that are U.S. FDA or EMA approved, specifically targeting unmet medical needs in the MENA regions.

Pharma Solutions is a UAE-based pharmaceutical company dedicated to enhancing patients' quality of life by providing innovative solutions and effective market access strategies for pharmaceutical products. With extensive knowledge of the regional healthcare industry, they position themselves as a key partner for biopharmaceutical manufacturers looking to enter the emerging markets of the GCC and MENA region.

Wellpharma Medical Solutions (WMS) is a leading pharmaceutical company in the UAE that specializes in the production of intravenous (IV) and dialysis products, including life-saving IV solutions. Their commitment to cGMP standards and quality management positions them as a key player in the biopharmaceutical sector, particularly in the production of therapeutic products.

PHARMALINK focuses on enhancing patient access to innovative healthcare solutions and medications, addressing emerging medical needs through a comprehensive service model that spans from market sensing to commercialization. Their extensive pharmaceutical experience and commitment to quality position them as a key player in the healthcare sector, dedicated to improving patient outcomes and empowering healthier lives.

Vieco Pharmaceuticals, founded in 2014, addresses the demand for high-quality medicines through advanced production technologies and adherence to international standards. Their commitment to providing effective and affordable medicines aligns with the biopharmaceutical focus on improving health outcomes.